INNEHÅLL 1. Erik Berntorp IHE pratar med ett urval av talarna pa IHE Forum 2017 2. Douglas Lundin & Ulf Persson 3. Mikael Svensson 4. Mef Nilbert 5. Toivo Heinsoo 6. Maria Palmetun Ekba ck 7. Flemming Sonne 7. Sofia Wallstro m 8. IHE:s publiceringar 2017 Q&A med Erik Berntorp, senior professor i klinisk koagulationsmedicin vid Lunds universitet IHE Institutet fo r ha lso och sjukva rdsekonomi Box 2127 220 20 Lund Beso ksadress Ra bygatan 2, Lund Telefon: 046 32 91 00 Email: ihe@ihe.se www.ihe.se 1
Q&A kring betalningsmodeller med Douglas Lundin, chefsekonom pa TLV, och Ulf Persson, VD pa IHE www.ihe.se 2
Q&A med SKL:s fo rhandlingskoordinator Mikael Svensson www.ihe.se 3
Q&A med den forskande la karen Mef Nilbert, professor i onkologi vid Lunds universitet www.ihe.se 4
Q&A med regeringens utredare fo r finansiering, subvention och prissa ttning av la kemedel, Toivo Heinsoo www.ihe.se 5
Q&A med chefen fo r La kemedelscentrum och ordfo rande i La kemedelskommitte n i Region Ö rebro la n, Maria Palmetun Ekbäck www.ihe.se 6
Q&A med Flemming Sonne, CEÖ fo r de danska regionernas la kemedelsorganisation Amgros Q&A med generaldirekto ren fo r Tandva rds- och La kemedelsfo rma nsverket, Sofia Wallström www.ihe.se 7
Persson S, Dahlquist G, Gerdtham UG, Steen Carlsson K. Why does childhoodonset type 1 diabetes impact labour market outcomes? A mediation analysis. Accepted in Diabetologia 2017 Gralén K, Elmér C, Broström E, Althin R and Malmberg L. Clincal practice of BOTOX treatment for overactive bladder syndrome in Sweden: an assessment of resource use and external validity. Scandinavian Journal of Urology. Published online: 05 Jul 2017. DOI: 10.1080/21681805.2017.1334697 Calara PS, Althin R, Inglese G and Nicholas T. Exploring patent activity and its potential association with healthcare outcomes: a case study of ostomy products in Sweden. International Journal of Technology Assessment in Health Care, 2017; 33(2): 168-175. DOI: https://doi.org/10.1017/ S0266462317000435 Persson U. En ny modell för prioritering och finansiering av läkemedel för mycket sällsynta sjukdomar. Rapport till kommissionen för innovativa särläkemedel, 2017 Olofsson S, Gerdtham UG, Hultkrantz L and Persson U. Measuring the end-of-life premium in cancer using individual ex ante willingness to pay. European Journal of Health Economics. First online: 12 August 2017. DOI: 10.1007/s10198-017-0922-6 Jönsson B, Hofmarcher T, Lindgren P, Moen F and Wilking N. Comparator Report on Patient Access to Cancer Medicines in Europe Revisited A UK Perspective. Lund, Sweden: IHE Report 2017:1 Norrlid H, Norlin J, Holmstrup H, Malmberg I, Sartorius K, Thormann H, Jemec G B.E. and Ragnarson Tennvall G. Patient-Reported Outcomes in Topical Field Treatment of Actinic Keratosis in Swedish and Danish Patients. Journal of Dermatological Treatment, 2017. Published Online: 29 June. DOI: https:// doi.org/10.1080/09546634.2017.1329514 Hjalte F, Steen Carlsson K and Schmitt- Egenolf M. Sustained PASI, DLQI and EQ-5D response of biological treatment in psoriasis: 10 years of real-world data in the Swedish National Psoriasis Register. The British Journal of Dermatology. Accepted manuscript online: 23 June 2017. DOI: 10.1111/bjd.15757 Persson S. Socioeconomic Consequences of Childhood Onset Type 1 Diabetes a case study of the impact of an early life health shock. Thesis 2017. Lund: Lund University, the Faculty of Medicine, Sweden. Andersson E, Toresson Grip E, Norrlid H & Fridhammar A. Samhällskostnaden för rökningsrelaterad sjuklighet i Sverige. IHE Rapport 2017:4. IHE: Lund, Sverige Gudnadottir G, Ragnarson Tennvall G, Stalfors J & Hellgren J. Indirect costs related to caregivers absence from work after paediatric tonsil surgery. European Archives of Oto-Rhino-Laryngology 2017. DOI: 10.1007/s00405-017-4526-7 Jarl J, Nilsson P, Gerdtham UG, Grahn B & Nyberg A. Hälsoekonomisk utvärdering av rehabiliteringsgarantin i Region Skåne en retrospektiv registerstudie. IHE Rapport 2017:3, IHE: Lund, Sverige Willis M, Johansen P, Nilsson A and Asseburg C. Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM) PharmacoEconomics 2017; 35(3): 375-96. DOI: 10.1007/ s40273-016-0471-3 Gralén K, Andersson E & Steen Carlsson K. Bemanning inom onkologiklinikerna i Sverige en enkätstudie för Cancerfonden. Lund: IHE Rapport 2017:2 Ragnarson Tennvall G & Fasth A. Cord blood transplantation, a cost-effective alternative: a health-economic analysis of the National Swedish Cord Blood Bank. Bone Marrow Transplantation, 2017 Apr; 52 (4): 638-640. DOI: doi:10.1038/ bmt.2016.333 Norlin JM, Calara PS, Persson U & Schmitt- Egenolf M. Real-world outcomes in 2,646 psoriasis patients: One in five has PASI 10 and/or DLQI 10 under ongoing systemic therapy. Journal of Dermatological Treatment, 2017. DOI: 10.1080/09546634.2017.1289147 Willis M, Asseburg C, Nilsson A, Johnsson K & Kartman B. Multivariate Prediction Equations for HbA1c Lowering, Weight Change, and Hypoglycemic Events Associated with Insulin Rescue Medication in Type 2 Diabetes Mellitus: Informing Economic Modelling. Value in Health, 2017 Mar; 20 (3): 357-371 DOI: http://dx.doi.org/10.1016/ j.jval.2016.10.004 Calara PS, Althin R, Steen Carlsson K & Schmitt-Egenolf M. Regional Differences in the Prescription of Biologics for Psoriasis in Sweden: A Register-Based Study of 4168 Patients. BioDrugs, 2017; 31(1): 75-82. DOI: 10.1007/s40259-016-0209-y Moen F, Svensson J and Steen Carlsson K. Assessing the value of cancer treatments from real world data Issues, empirical examples and lessons learnt. Journal of Cancer Policy 2017; 11: 32 37. DOI: http:// dx.doi.org/10.1016/j.jcpo.2016.11.001 Lindgren P, Jönsson B & Wilking N. Assessment of value for resource allocation in cancer care. Journal of Cancer Policy 2017 11: 12-18. DOI: http:// dx.doi.org/10.1016/j.jcpo.2016.11.001 Ericsson Å & Lundqvist A. Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden. Applied Health Economics and Health Policy, 2017; 15: 237-248. DOI: http:// dx.doi.org/10.1007/s40258-016-0301-y Jönsson B. Editorials: Evidence, value and hope Allocating resources for cancer. Journal of Cancer Policy, 2017; 11: 1-5. DOI: http://dx.doi.org/10.1016/ j.jcpo.2016.11.002 På IHE:s hemsida under Publiceringar kan du söka bland de publikationer som IHE:s personal har medverkat i och under arkivet finns publiceringar listade efter utgivningsår och författare. www.ihe.se 8